| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/10/2007 | US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene |
| 07/10/2007 | US7241450 DNA sequence and recombinant production of a Gramineae allergen |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/05/2007 | WO2007076295A2 Nanoclusters for delivery of therapeutics |
| 07/05/2007 | WO2007075753A2 High through-put method of screening compounds for pharmacological activity |
| 07/05/2007 | WO2007075565A2 Diagnostic system for the detection and diagnosis of skin cancer |
| 07/05/2007 | WO2007073792A1 Process for preparing 4,4- diphenylcyclohexanol |
| 07/05/2007 | WO2007073643A1 Ultrasonic coupling agent and its preparation process and packaging container contg.same |
| 07/05/2007 | WO2007055995A3 Nanoparticle-based imaging agents for x-ray/computed tomography |
| 07/05/2007 | WO2007054182A3 Nanoparticles used as contrasting agents in magnetic resonance imaging |
| 07/05/2007 | WO2006022754A3 Radiopaque polymeric stents |
| 07/05/2007 | WO2005115482A3 Methods for identifying chemical modulators of ras superfamily gtpase activity |
| 07/05/2007 | US20070156046 Method of enriching hyperpolarized atom nuclei and an apparatus for implementing the method |
| 07/05/2007 | US20070155772 Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease |
| 07/05/2007 | US20070155701 Keto cannabinoids with therapeutic indications |
| 07/05/2007 | US20070154452 Therapeutic agent for pancreas cancer |
| 07/05/2007 | US20070154399 Immunotherapy for immune suppressed patients |
| 07/05/2007 | US20070154398 Block copolymers and nano micelles comprising the same |
| 07/05/2007 | US20070154397 Thermosensitive nanostructure for hyperthermia treatment |
| 07/05/2007 | US20070154396 Block copolymers and nano micelles comprising the same |
| 07/05/2007 | US20070154395 in vivo screening assay and an in vitro screening assay for rapid screening of diabetes. A method of the invention includes determining a first glucose concentration in an ocular fluid of a patient; administering orally a load of carbohydrate to the patient; determining a second glucose concentration |
| 07/05/2007 | US20070154394 Diagnostic agents for pancreatic exocrine function |
| 07/05/2007 | US20070154393 Bioassay for volatile low molecular weight insecticides and methods of use |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | US20070154390 Nuclear molecular imaging contrast agent |
| 07/05/2007 | US20070151631 Magnetic nanoparticles of noble metals |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | CA2633380A1 Nanoclusters for delivery of therapeutics |
| 07/04/2007 | EP1803711A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 07/04/2007 | EP1802352A1 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
| 07/04/2007 | EP1802317A2 Use of a2a adenosine receptor agonists |
| 07/04/2007 | CN1993462A Adenoviral vector compositions |
| 07/04/2007 | CN1993357A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 07/04/2007 | CN1993147A Ultrasonic contrast agent dosage formulation |
| 07/04/2007 | CN1991367A Liver function test |
| 07/04/2007 | CN1990048A Ultrasonic therapy couplant, its preparing process and packing apparatus |
| 07/03/2007 | US7238814 For measuring vasodilation or changes in blood flow in a patient |
| 07/03/2007 | US7238369 a cationic lipid; and a taxane in a lipid bilayer of the taxane crystal free liposome |
| 07/03/2007 | US7238358 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/03/2007 | US7238341 Peptide-based multimeric targeted contrast agents |
| 07/03/2007 | US7238340 Monoamine, diamide, thiol-containing metal chelating agents |
| 07/03/2007 | CA2297399C Method for detection of fibrin clots |
| 07/03/2007 | CA2108192C Use of tyloxapol as a nanoparticle stabilizer and dispersant |
| 07/03/2007 | CA2092567C Nt-4 neurotrophic factor |
| 06/28/2007 | WO2007072983A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 06/28/2007 | WO2007072982A1 Protein nanoparticles and the use of the same |
| 06/28/2007 | WO2007053698A3 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 06/28/2007 | WO2007021423A3 Gene disruptions, compositions and methods relating thereto |
| 06/28/2007 | WO2007007100A3 Measurement of gastric acid secretion |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149503 Anti-migraine spirocycles |
| 06/28/2007 | US20070149502 Spirocyclic anti-migraine compounds |
| 06/28/2007 | US20070149496 Water-soluble compound |
| 06/28/2007 | US20070149483 Methods and compounds for modulating triglyceride and vldl secretion |
| 06/28/2007 | US20070148097 Abuse resistant transmucosal drug delivery device |
| 06/28/2007 | US20070148096 Contrast Agents |
| 06/28/2007 | US20070148095 Fluorescent magnetic nanoparticles with specific targeting functions |
| 06/28/2007 | US20070148094 Polymeric imaging agents and medical imaging methods |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | US20070148074 Nanoparticle based stabilization of ir fluorescent dyes |
| 06/28/2007 | DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis |
| 06/28/2007 | DE102006057548A1 Histologische Färbezusammensetzung für Endoskope Histological staining composition for endoscopes |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | EP1799865A2 Methods for the administration of iloperidone |
| 06/27/2007 | EP1799273A2 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 06/27/2007 | EP1799268A2 Magnetic particles for therapy and diagnosis |
| 06/27/2007 | EP1492570A4 Method of diagnosis and treatment of breast lesions |
| 06/27/2007 | EP1465678B1 A new bone mineral substitute |
| 06/27/2007 | EP1368065B1 Paramagnetic nanoparticle |
| 06/27/2007 | EP1330646A4 Methods for detecting vasculopathies and tumors |
| 06/27/2007 | EP1107743B1 Stable spray-dried protein formulations |
| 06/27/2007 | CN1989410A Immune response assessment method |
| 06/27/2007 | CN1988919A Liposome-containing radiographic contrast medium and preparation method thereof |
| 06/27/2007 | CN1988915A Multiple agent therapy for sexual dysfunction |
| 06/27/2007 | CN1988848A Carboranylporphyrins and uses thereof |
| 06/27/2007 | CN1986549A Tumor-targeting dendritic macromolecular paramagnetic metal complex and its synthesis process and use |
| 06/27/2007 | CN1985996A Microbulb ultrasonic contrast medium and its connection method with antibody, targeting gene and gene |
| 06/26/2007 | US7235625 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture |
| 06/26/2007 | US7235375 Organic anion transport proteins |
| 06/26/2007 | US7235228 Chemical reduction process to form magnetic metal core, sulfiding to form metal sulfide seed crystal, coating a fluorescent semiconductor material on sulfide surface; biosensors with optical and magnetical activities, visual detection of a test strip |
| 06/26/2007 | US7235227 Paramagnetic particles that provide improved relaxivity |
| 06/26/2007 | US7234469 Surface topography method for determining effect of a botulinum toxin upon a muscle |
| 06/26/2007 | CA2301716C Diagnosis kit for skin test and method for carrying out the same |
| 06/21/2007 | WO2007070827A2 Contrast agents for myocardium perfusion imaging |
| 06/21/2007 | WO2007070682A2 System for screening particles |
| 06/21/2007 | WO2007070623A2 Transcatheter tumor immunoembolization |
| 06/21/2007 | WO2007070466A2 In situ hyperpolarization of imaging agents |
| 06/21/2007 | WO2007070195A2 Compositions, methods of preparing amino acids and nuclear magnetic resonance spectroscopy |
| 06/21/2007 | WO2007069040A2 Targeted nanoparticles for magnetic resonance imaging |
| 06/21/2007 | WO2007051739A3 X-ray system for the creation of diagnostic x-ray images using contrast media |
| 06/21/2007 | WO2006114738A3 Mri contrast agents comprising cest active paramagnetic complex |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | US20070143865 Methods of screening agents for activity using teleosts |
| 06/21/2007 | US20070142468 Compositions containing prodrugs of florfenicol and methods of use |
| 06/21/2007 | US20070142296 D-amino acid peptides |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070141653 Method for diagnosing infectious diseases |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070140974 Targeted nanoparticles for magnetic resonance imaging |
| 06/21/2007 | US20070140973 Contrast agents for myocardium perfusion imaging |